Proarrhythmic safety of repeat doses of mirabegron in healthy subjects: a randomized, double-blind, placebo-, and active-controlled thorough QT study - Malik, M; van Gelderen, E M; Lee, J H (Clin Pharmacol Ther, 2012)
et al.